These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1582018)

  • 1. Reference intervals for eight modified nucleosides in serum in a healthy population from Italy and the United States.
    Pane F; Oriani G; Kuo KC; Gehrke CW; Salvatore F; Sacchetti L
    Clin Chem; 1992 May; 38(5):671-7. PubMed ID: 1582018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
    Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
    Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
    Heldman DA; Grever MR; Miser JS; Trewyn RW
    J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/electrospray mass spectrometry.
    Dudley E; Lemière F; Van Dongen W; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2004; 18(22):2730-8. PubMed ID: 15499664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.
    Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O
    Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides.
    Tormey DC; Waalkes TP; Ahmann D; Gehrke CW; Zumwatt RW; Snyder J; Hansen H
    Cancer; 1975 Apr; 35(4):1095-100. PubMed ID: 1116102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
    Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
    J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential excretion of modified nucleosides in adult acute leukemia.
    Heldman DA; Grever MR; Trewyn RW
    Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of 7-methylguanine, N2,N2-dimethylguanosine, and pseudouridine in ultrafiltrated serum of healthy adults by high-performance liquid chromatography.
    Topp H; Sander G; Heller-Schöch G; Schöch G
    Anal Biochem; 1987 Feb; 161(1):49-56. PubMed ID: 2437827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA; Grever MR; Speicher CE; Trewyn RW
    J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.
    Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified nucleosides in human serum.
    Mitchell EP; Evans L; Schultz P; Madsen R; Yarbro JW; Gehrke CW; Kuo K
    J Chromatogr; 1992 Oct; 581(1):31-40. PubMed ID: 1430005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversed-phase high-performance liquid chromatographic investigation of mucosal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients.
    Nakano K; Shindo K; Yasaka T; Yamamoto H
    J Chromatogr; 1985 Sep; 343(1):21-33. PubMed ID: 4066857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers.
    Liebich HM; Müller-Hagedorn S; Klaus F; Meziane K; Kim KR; Frickenschmidt A; Kammerer B
    J Chromatogr A; 2005 Apr; 1071(1-2):271-5. PubMed ID: 15865203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of lung cancer patients and controls by chromatography of modified nucleosides in serum.
    McEntire JE; Kuo KC; Smith ME; Stalling DL; Richens JW; Zumwalt RW; Gehrke CW; Papermaster BW
    Cancer Res; 1989 Feb; 49(4):1057-62. PubMed ID: 2912551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma.
    Djukovic D; Baniasadi HR; Kc R; Hammoud Z; Raftery D
    Rapid Commun Mass Spectrom; 2010 Oct; 24(20):3057-62. PubMed ID: 20872639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleosides in human urine. I. Isolation and identification of N2-dimethylguanosine, 1-methylinosine, and N2-methylguanosine from normal human urine.
    Chheda GB; Mittelman A; Grace JT
    J Pharm Sci; 1969 Jan; 58(1):75-8. PubMed ID: 5765842
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
    Tormey DC; Waalkes TP; Gehrke CW
    J Surg Oncol; 1980; 14(3):267-73. PubMed ID: 7392649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM; Di Stefano C; Wixforth A; Schmid HR
    J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.